These drugs work by mimicking a hormone the body produces naturally, one that slows digestion, stimulates insulin production, and signals the brain to reduce appetite
The medication works by mimicking a hormone that influences appetite regulation, helping to curb hunger and reduce the overall urge to eat
Conclusion The field of anti-obesity drug development is rapidly evolving, with new therapies emerging that offer the potential for more effective and personalised weight management
Studies have shown that people taking oral semaglutide lost more weight compared to those not taking the medicine
Obesity is a chronic, multifactorial disease with increasing prevalence and significant metabolic, cardiovascular, and hepatic complications
We also confirmed that the association of rs10305420 with GLP1 medication efficacy cannot be accounted for by T2D or smoking status (Supplementary Information and Supplementary Tables 7 and 8)